M. E. Whisson
Impact in
- Toxicology top 1%
- Bioactive Compounds and Antitumor Agents
- Biochemistry top 5%
- Blood transfusion and management
Papers in
-
- Blood transfusion and management 8
-
- Platelet Disorders and Treatments 4
- Multiple Myeloma Research and Treatments 4
- Co-authors
- T.A. Connors (7 shared papers)M. Guppy (10 shared papers)M. Szekerke (3 shared papers)Walter C. J. Ross (1 shared paper)Abdul Hameed Khan (1 shared paper)Loren Cobb (1 shared paper)L. A. Elson (1 shared paper)Bernard C.V. Mitchley (1 shared paper)
- Journals
- Nature (4 papers)Biochemical Pharmacology (3 papers)British Journal of Haematology (3 papers)Transfusion Medicine (2 papers)Analytical Biochemistry (1 paper)
- Partner nations
- AustraliaUnited KingdomHungary
In The Last Decade
M. E. Whisson
25 papers receiving 579 citations
Peers
Comparison fields: 5 of 54
- Toxicology 144
- Biochemistry 106
- Biomaterials 73
- Pharmacology 47
- Cancer Research 60
Countries citing papers authored by M. E. Whisson
This map shows the geographic impact of M. E. Whisson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. E. Whisson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. E. Whisson more than expected).
Fields of papers citing papers by M. E. Whisson
This network shows the impact of papers produced by M. E. Whisson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. E. Whisson. The network helps show where M. E. Whisson may publish in the future.
Co-authors
The 25 scholars most cited alongside M. E. Whisson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1966 | 129 | |
| 2 | 1969 | 109 | |
| 3 | 1990 | 72 | |
| 4 | 1966 | 67 | |
| 5 | 1965 | 48 | |
| 6 | 1967 | 42 | |
| 7 | 1995 | 40 | |
| 8 | The use of macromolecules as carriers of cytotoxic groups (part I) conjugates of nitrogen mustards with proteins, polypeptidyl proteins and polypeptides. | 1972 | 28 |
| 9 | The use of macromolecules as carriers of cytotoxic groups (part II) nitrogen mustard--protein complexes. | 1972 | 23 |
| 10 | 1993 | 22 | |
| 11 | 1996 | 19 | |
| 12 | 1965 | 18 | |
| 13 | 1982 | 12 | |
| 14 | 1964 | 10 | |
| 15 | 1966 | 9 | |
| 16 | 1977 | 8 | |
| 17 | 1995 | 6 | |
| 18 | 1997 | 6 | |
| 19 | 1965 | 4 | |
| 20 | Fructose formation in stored blood. | 1990 | 4 |
About M. E. Whisson
M. E. Whisson is a scholar working on Biochemistry, Hematology, Toxicology, Cancer Research and Pathology and Forensic Medicine, having authored 25 papers that have together received 686 indexed citations. Recurring topics across this work include Blood transfusion and management (8 papers), Bioactive Compounds and Antitumor Agents (5 papers), Platelet Disorders and Treatments (4 papers), Multiple Myeloma Research and Treatments (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer therapeutics and mechanisms (3 papers), Toxin Mechanisms and Immunotoxins (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). The work is most often cited by research in Toxicology (144 citations), Biochemistry (106 citations), Biomaterials (73 citations), Pharmacology (47 citations) and Cancer Research (60 citations). M. E. Whisson has collaborated with scholars based in Australia, United Kingdom and Hungary. Frequent co-authors include T.A. Connors, M. Guppy, M. Szekerke, Walter C. J. Ross, Abdul Hameed Khan, Loren Cobb, L. A. Elson, Bernard C.V. Mitchley, Lindy Abas and Peter G. Arthur. Their work appears in journals such as Nature, Biochemical Pharmacology, British Journal of Haematology, Transfusion Medicine and Analytical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.